Awm Investment Company Inc
- Regulatory AUM
- $1.3B
- Discretionary
- $1.3B
- Clients
- 8
- Avg AUM / client
- $165M
- Accounts
- 8
- Employees
- 14
AUM over time
Reported AUM from Form ADV filings, plotted by filing date · as of Mar 31, 2026
Investments (13F portfolio — 98 positions, $903,396,082)
13F period Mar 31, 2026| # | Issuer | Class | Value | Shares | % of 13F | % of AUM |
|---|---|---|---|---|---|---|
| 1 | Aehr Test Systems | COM | $59,104,445 | 1,593,971 | 6.54% | 4.49% |
| 2 | N Light, Inc. | COM | $58,373,598 | 1,023,739 | 6.46% | 4.43% |
| 3 | Vicor Corporation | COM | $46,396,980 | 288,180 | 5.14% | 3.52% |
| 4 | Black Sky Technology, Inc. | COM | $43,416,348 | 1,725,610 | 4.81% | 3.3% |
| 5 | Gilat Satellite Networks, Ltd. | COM | $34,587,560 | 2,302,767 | 3.83% | 2.63% |
| 6 | 908 Devices, Inc. | COM | $31,823,535 | 5,199,924 | 3.52% | 2.42% |
| 7 | American Superconductor Corp | COM | $27,134,295 | 801,604 | 3.0% | 2.06% |
| 8 | Kopin Corporation | COM | $26,583,327 | 11,814,812 | 2.94% | 2.02% |
| 9 | Aerovironment, Inc. | COM | $23,916,947 | 130,658 | 2.65% | 1.82% |
| 10 | Impinj, Inc. | COM | $21,260,749 | 207,018 | 2.35% | 1.61% |
| 11 | Light Path Technologies, Inc. | COM | $20,437,228 | 2,037,610 | 2.26% | 1.55% |
| 12 | Definium Therapeutics, Inc. | COM | $20,353,278 | 1,076,893 | 2.25% | 1.55% |
| 13 | Talkspace, Inc. | COM | $19,804,166 | 3,826,892 | 2.19% | 1.5% |
| 14 | Velo3 D, Inc. | COM | $18,576,068 | 1,978,282 | 2.06% | 1.41% |
| 15 | Everspin Technology, Inc. | COM | $18,258,948 | 2,077,241 | 2.02% | 1.39% |
| 16 | Arlo Technologies, Inc. | COM | $18,002,501 | 1,265,109 | 1.99% | 1.37% |
| 17 | Butterfly Network, Inc. | COM | $17,899,596 | 4,430,593 | 1.98% | 1.36% |
| 18 | Universal Technical Institute, | COM | $17,656,438 | 489,098 | 1.95% | 1.34% |
| 19 | Ceva, Inc. | COM | $16,154,576 | 864,806 | 1.79% | 1.23% |
| 20 | Power Fleet, Inc. | COM | $14,480,638 | 4,701,506 | 1.6% | 1.1% |
| 21 | The Real Real, Inc. | COM | $13,473,331 | 1,483,847 | 1.49% | 1.02% |
| 22 | Radcom, Ltd. (Israel) | COM | $12,053,734 | 991,261 | 1.33% | 0.92% |
| 23 | M Dx Health, Sa (Belgium) | COM | $12,008,949 | 5,221,282 | 1.33% | 0.91% |
| 24 | Strata Critical Medical, Inc. | COM | $11,793,736 | 2,821,468 | 1.31% | 0.9% |
| 25 | Genasys, Inc. (F4) | COM | $10,282,170 | 5,649,544 | 1.14% | 0.78% |
Top 25 of 98 positions from the manager's latest Form 13F · source filing (EDGAR) ↗. 13F covers long US-listed positions only. "% of AUM" is share of the firm's total regulatory AUM (Form ADV Item 5.F).
Who they serve
| Client type | Clients | AUM | % of AUM |
|---|---|---|---|
| Pooled investment vehicles (non-investment companies) | 8 | $1.3B | 100.0% |
Private funds (8)
Reported in Form ADV Section 7.B.(1), filing of Mar 2024 · $900M combined gross assets
| Fund | Type | Domicile | Gross assets | Owners |
|---|---|---|---|---|
| Special Situations Fund Iii Qp, L.P. | Hedge Fund | Delaware | $381M | 99 |
| Special Situations Technology Fund Ii, L.P. | Hedge Fund | Delaware | $168M | 55 |
| Special Situations Life Sciences Fund, L.P. | Hedge Fund | Delaware | $119M | 60 |
| Special Situations Cayman Fund, L.P. master | Hedge Fund | Cayman Islands | $111M | 48 |
| Special Situations Private Equity Fund, L.P. | Hedge Fund | Delaware | $65.7M | 32 |
| Special Situations Technology Fund, L.P. | Hedge Fund | Delaware | $31.6M | 36 |
| Life Sciences Innovation Fund, L.P. | Venture Capital Fund | Delaware | $14.3M | 39 |
| Life Sciences Innovation Fund Ii, L.P. | Venture Capital Fund | Delaware | $10.8M | 35 |
People (5)
| Name | Role / title | Credentials | With firm since | Ownership |
|---|---|---|---|---|
| Greenhouse, David, Michael | President | Jun 2022 (4y) | 50% – 75% | |
| Marxe, Austin, Wolfe | Owner | Jun 2022 (4y) | 5% – 10% | |
| Stettner, Adam, Charles | Executive Vice President | Jun 2022 (4y) | 25% – 50% | |
| Hicks Kelly, Marianne | Chief Administrative Officer | Mar 2024 (2y) | Less than 5% | |
| Reif, David, Alan | Chief Compliance Officer | Mar 2024 (2y) | Less than 5% |
Undisclosed: 0% – 20% of the firm is not attributable from the filed Schedule A bands.
Roster from the IAPD representatives feed; ownership and acquisition dates from Form ADV Schedule A/B. "Since" is the earliest filed registration or acquisition date.
Private funds (8, $900M gross assets)
| Fund | Type | Gross assets | Min. investment | Owners |
|---|---|---|---|---|
| Special Situations Fund Iii Qp, L.P. | Hedge Fund | $381M | $100K | 99 |
| Special Situations Technology Fund Ii, L.P. | Hedge Fund | $168M | $100K | 55 |
| Special Situations Life Sciences Fund, L.P. | Hedge Fund | $119M | $250K | 60 |
| Special Situations Cayman Fund, L.P. | Hedge Fund | $111M | $100K | 48 |
| Special Situations Private Equity Fund, L.P. | Hedge Fund | $65.7M | $100K | 32 |
| Special Situations Technology Fund, L.P. | Hedge Fund | $31.6M | $100K | 36 |
| Life Sciences Innovation Fund, L.P. | Venture Capital Fund | $14.3M | $100K | 39 |
| Life Sciences Innovation Fund Ii, L.P. | Venture Capital Fund | $10.8M | $100K | 35 |
From Form ADV Section 7.B private fund reporting.
Documents (1 archived)
| Form | Period | Size | |
|---|---|---|---|
| Form ADV (full filing) | 03/31/2026 | 2.79 MB | View · PDF · Source ↗ |
Archived copies of the firm's regulatory filings, versioned by content hash.
Disciplinary disclosures
No disciplinary events reported on the firm's latest Form ADV filing.
How they charge
- • Percentage of assets under management
Services
- • Portfolio management for pooled investment vehicles
Custody
Firm reports having custody of client funds or securities (Item 9.A).
No custodian data reported or mined yet.
Source
All data on this page comes from this firm's Form ADV filings, reproduced without modification. Latest filing: Mar 31, 2026.
View current Form ADV (SEC/IAPD) ↗